Viewing Study NCT00549757

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2026-04-06 @ 10:53 AM
Study NCT ID: NCT00549757
Status: TERMINATED
Last Update Posted: 2014-04-21
First Post: 2007-10-24
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
None Cardiovascular Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 diabetes mellitus View
None renal morbidity and mortality View
None cardiovascular disease View
None micro-albuminuria View
None macro-albuminuria View
None RAAS View
None renin inhibitor View
None Reduced estimated glomerular filtration rate View